Tumorigenesis and metastasis during cancer development inherently involve the hyperactivation of classic oncogenic signaling pathways, among which the Wnt/β-catenin, Notch, and PI3K/AKT signaling pathways are widely acknowledged [11, 29–31]. This evidence concerns the gene AKT1 and cancer.